Pfizer Inc. (PFE), the world’s biggest drugmaker, said it has no plans to break up the company’s animal health unit after Eli Lilly & Co. (LLY) expressed interest in buying some of its products. Lilly, which had $1.39 billion in sales from animal-health products last year, is monitoring Pfizer’s plans to divest its unit and will pursue assets deemed of interest, Chief Financial Officer Derica Rice said today in a conference call. Pfizer wants a sale or spinoff of the unit and doesn’t foresee breaking it up, said Joan Campion, a company spokeswoman.
